Combined use of Bifidobacterium, Lactobacillus, Enterococcus, and Bacillus cereus tablets alleviates DSS-induced colitis by modulating gut microbiota and increasing putrescine production
This study investigates the therapeutic effects of a combined probiotic formulation containing Bifidobacterium, Lactobacillus, Enterococcus, and Bacillus cereus tablets on Dextran Sulfate Sodium (DSS)-induced colitis. We aim to elucidate the underlying mechanisms by analyzing the modulation of gut microbiota composition and the associated increase in putrescine production. Our results will provide insights into how these specific probiotics synergistically alleviate intestinal inflammation via the microbiota-metabolite axis.